Egnyte is integral to our ability to automate much of our data management, which has made the often complex process of working with external partners much smoother, more reliable, and more efficient.
It's been exciting to see the Egnyte product offering evolve in a way that fits extremely well with the way that biotech companies start and grow. These GXP offerings are something that early biotech companies can lean into to accelerate their launch into clinical stage operations.
We are putting all documentation submitted to FDA and other regulatory agencies in Egnyte, so that now and in the future, people know where to find the actual documentation that was given to the agencies for review.
Heather Wolff
Vice President, Clinical Development Operations, Decibel Therapeutics